BRKR
BRKR
NASDAQ · Life Sciences Tools & Services

Bruker Corp

Mid-Cap Stocks Healthcare Stocks Best Dividend Stocks
$41.93
+0.89 (+2.17%)
As of Feb 8, 3:10 PM ET ·
Analyst Consensus
Buy
22
Analysts
High
Coverage
Buy 15 68%
Hold 6 27%
Sell 1 5%
Price Target
Analyst Price Target +125.6% upside
Low Target $62.72
Average Target $94.60
High Target $105.77
Current Price $41.93
Current
$41.93
Target
$94.60
$62.72 $94.60 avg $105.77
Scenario Analysis
Bear Case
$62.72
49.6%
Low target
Base Case
$94.60
+125.6%
Avg target
Bull Case
$105.77
+152.3%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$57.64
-27.3% from high
52-Week Low
$28.53
+47.0% from low
50-Day SMA
$47.78
-12.2% vs SMA
200-Day SMA
$40.08
+4.6% vs SMA
RSI (14)
29.6
Oversold
Target vs 52W High
$94.60
+64.1% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
 Strong Buy 31 87% $158.11 -27.0%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
 Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
 Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -45.3%